Article

The Challenges Facing Abuse-Deterrent Opioids

Conference|PAINWeek Conference

In this video from PainWeek 2017, Jeremy Adler, MS, PA-C, co-owner of Pacific Pain Medicine, discusses the challenges facing abuse-deterrent opioids as their manufacturers attempt to bring them to market.

In this video from PainWeek 2017, Jeremy Adler, MS, PA-C, co-owner of Pacific Pain Medicine, discusses the challenges facing abuse-deterrent opioids as their manufacturers attempt to bring them to market.

Related Videos
Related Content
Research Shows Guillain-Barré Syndrome Remains Rare Among Older Adults After RSV Vaccination
December 21st 2024

Research Shows Guillain-Barré Syndrome Remains Rare Among Older Adults After RSV Vaccination

Aislinn Antrim, Assistant Managing Editor
Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes
November 21st 2024

Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes

Christina M. Madison, PharmD, FCCP, AAHIVP
HIV test strip | Image Credit: © Mulin - stock.adobe.com
December 21st 2024

FDA Approves Premarket Approval Application for OraQuick HIV Self-Test, Expanding Access to Adolescents

Alexandra Gerlach, Associate Editor
Public Health Matters podcast logo
September 19th 2024

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

FDA Approval, Weight Loss, Pediatrics | Image Credit: Aquir | stock.adobe.com
December 20th 2024

FDA Approves Expanded Indication for Setmelanotide to Include Patients 2 and Older

Ashley Gallagher, Associate Editor
Varicella zoster or chickenpox virus, ai illustration. A herpes virus which cause chickenpox and shingles - Image credit: Cristina | stock.adobe.com
December 20th 2024

Study: Fatal Disseminated Herpes Zoster in Immunocompetent Individuals

Kennedy Ferruggia, Assistant Editor